CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S21, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER Ponce LN, Brizuela NY. Cátedra de Farmacología General. Facultad de Ciencias Médicas .Universidad Nacional de Córdoba. Argentina. E-mail: … Continue reading CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER

J Pharm Pharmacogn Res 2(Suppl. 1): S21, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 039: RATIONAL USE OF MEDICINES IN PRIMARY HEALTH CARE: POLYPHARMACY IN PEOPLE AGED 60 YEARS AND OLDER

Ponce LN, Brizuela NY.

Cátedra de Farmacología General. Facultad de Ciencias Médicas .Universidad Nacional de Córdoba. Argentina. E-mail: lucinuri2011@gmail.com
Abstract

Introduction: Pharmacotherapy in the elderly population is complicated by several factors that increase the risk of drugs. Rational use of medicines refers to the correct, proper and appropriate use of medicines. More than 50% of all medicines are prescribed, dispensed or sold inappropriately, and half of all patients fail to take medicines correctly. This article aims to highlight the increasing impact of polypharmacy in the elderly patients.

Methodology: The present study is prospective in nature, descriptive, cross sectional, carried out between February and May 2011, in a primary care clinic at a senior center in the city of Cordoba, Argentina.

Results: In this sample, 74.21% used from 5 to 8 medicines daily; all of them used to take each medication at least 3 times daily. In this sample, 73.04% had increased risk of adverse drug reaction (ADRs) and 78% came from different physicians. A third (34%) of the patients was treated predominately with cardiovascular diseases drugs. Metabolic diseases (25%), digestive illness (14.5%), neurological and psychiatric disorders (14.5%) and the others (14.5%). A quarter (25%) of the patients was treated with very little therapeutic value drugs.

Conclusions: Polypharmacy, as well as inappropriate prescribing, for the elderly is a major problem and a challenge that contributes to costs, adverse drug events, confusion, compliance issues, and errors in management. A systematic approach to drug monitoring is an important aspect of appropriate prescribing. Attention to prescribing of medications, consistent review of medication lists, and reevaluation of indications and outcomes of prescribing are essential to ensure that polypharmacy is minimized and safety for patients is maximized.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio